These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10761465)

  • 1. An overlooked factor VLeiden autopsy study.
    Dunn ST
    Am J Clin Pathol; 2000 Apr; 113(4):595-6. PubMed ID: 10761465
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of the factor VLeiden mutation among autopsy patients with pulmonary thromboembolic disease using an improved method for factor VLeiden detection.
    Gorman TE; Arcot AN; Baker P; Prior TW; Brandt JT
    Am J Clin Pathol; 1999 Mar; 111(3):413-7. PubMed ID: 10078118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prothrombin gene mutation uncommon in pulmonary embolism.
    Kohlmeier RE; Cho CG; Bux RC; Guerra L; Rulon JJ; Selby DM; Gulley ML
    South Med J; 2000 Nov; 93(11):1073-7. PubMed ID: 11095555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers.
    Morange PE; Aillaud MF; Nicaud V; Henry M; Juhan-Vague I
    Thromb Haemost; 2001 Dec; 86(6):1583-4. PubMed ID: 11776333
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V Leiden and prothrombin 20210 G-A mutations in controls and in patients with thromboembolic events during pregnancy or the puerperium.
    Yilmazer M; Kurtay G; Sonmezer M; Akar N
    Arch Gynecol Obstet; 2003 Oct; 268(4):304-8. PubMed ID: 14504875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the factor V Leiden mutation using the READIT Assay.
    Rhodes RB; Lewis K; Shultz J; Huber S; Voelkerding KV; Leonard DG; Tsongalis GJ; Kephart DD
    Mol Diagn; 2001 Mar; 6(1):55-61. PubMed ID: 11257212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged seated immobility-associated venous coagulability in a factor V Leiden heterozygote: a case-comparative study.
    Ansari MT; Cheung BM; Karlberg JP
    Blood Coagul Fibrinolysis; 2006 Apr; 17(3):187-91. PubMed ID: 16575256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Factor V Leiden and prothrombin G20210A in patients submitted to stem cell transplantation.
    Chiusolo P; Sica S; De Stefano V; Casorelli I; Laurenti L; Leone G
    Haematologica; 2000 Jun; 85(6):670-1. PubMed ID: 10870132
    [No Abstract]   [Full Text] [Related]  

  • 10. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV; Kirienko AI; Kozhevnikova LM; Shostak NA; Babadaeva NM; Leont'ev SG; Petukhov EB; Kubatiev AA; Savel'ev VS
    Ter Arkh; 2006; 78(6):70-6. PubMed ID: 16881367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Breakthrough in thrombosis research--can the use of contraceptive pills be safer than it used to be?].
    Lähteenmäki P
    Duodecim; 1995; 111(22):2097-8. PubMed ID: 9841168
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pulmonary arterial thromboembolism and thrombophilias: optimization of diagnostics and treatment].
    Nikitin AV; Ipatov PV; Fursov AN; Kolebaev DV
    Klin Med (Mosk); 2006; 84(6):21-4. PubMed ID: 16875063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
    Robison NJ; Dawlabani N; Lastra CR; Dhall G
    Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic granulomas and heterozygote Leiden mutation in a patient with idiopathic portal hypertension.
    Yildirim B; Ozenirler S; Sancak A; Unal S; Demirci T; Akyol G
    J Gastrointestin Liver Dis; 2007 Dec; 16(4):467-8. PubMed ID: 18193134
    [No Abstract]   [Full Text] [Related]  

  • 15. High plasma levels of factor VIII: an important risk factor for isolated pulmonary embolism.
    Erkekol FO; Ulu A; Numanoglu N; Akar N
    Respirology; 2006 Jan; 11(1):70-4. PubMed ID: 16423204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of factor V Leiden in surgical patients with symptomatic venous thromboembolism despite prophylaxis.
    Baba-Ahmed M; Le Gal G; Couturaud F; Lacut K; Oger E; Leroyer C
    Thromb Haemost; 2007 Feb; 97(2):171-5. PubMed ID: 17264942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK; Yilmaz E; Demirtas S; Erkekol FO; Ekim N; Demir N; Numanoglu N; Ozel D; Ulu A; Akar N
    Clin Appl Thromb Hemost; 2009 Feb; 15(1):73-7. PubMed ID: 18160588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is lifetime anticoagulation required in factor V Leiden mutation?].
    Pötzsch B
    Dtsch Med Wochenschr; 2003 Jul; 128(30):1617. PubMed ID: 12884152
    [No Abstract]   [Full Text] [Related]  

  • 19. The factor V Leiden and prothrombin G20210A mutations in Kirghiz population.
    Gurgey A; Kudayarov DK; Tuncer M; Parlak H; Altay C
    Thromb Haemost; 2000 Aug; 84(2):356. PubMed ID: 10959716
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor V Leiden and sepsis: Proof positive or phenomenology?
    Parker RI
    Crit Care Med; 2006 Aug; 34(8):2254-5. PubMed ID: 16883201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.